The clinical aspects of a preparation «Divigel»

In the last years both in our country, and abroad with the purpose of climacteric syndrome treatment, and also for preventive osteoporosis maintenance in heart diseases is used with success a hormonal replacement therapy (HRT) with, estrogens and gestagens. The carried out research has proved, that the «Divigel» drug has high efficiency and acceptability in climacteric syndrome treatment. Thus the percentage of side-effect reactions at its application is minimal. Besides one of the advantages of a preparation is the transdermal way of introduction, that allows to avoid hormonal metabolic changes in primary passage through a liver and to avoid occurrence of irritation by-effects on the digestive system.